Previous Close | 90.11 |
Open | 90.28 |
Bid | 88.00 x 800 |
Ask | 89.38 x 900 |
Day's Range | 88.58 - 90.47 |
52 Week Range | 60.57 - 96.12 |
Volume | |
Avg. Volume | 3,309,777 |
Market Cap | 53.716B |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | 38.42 |
EPS (TTM) | 2.32 |
Earnings Date | Jul 24, 2024 - Jul 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 96.17 |
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...
Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.
NYON, Switzerland, May 08, 2024--Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.*